Bioengineering
Studies from Center for Cancer Research reveal new findings on bioengineering
Published in Drug Week, August 24th, 2007
Scientists discuss in "Rifaximin is a gut-specific human pregnane X receptor activator" new findings in bioengineering. According to a study from the United States, "Rifaximin, a rifamycin analog approved for the treatment of travelers' diarrhea, is also beneficial in the treatment of multiple chronic gastrointestinal disorders. However, the mechanisms contributing to the effects of rifaximin on chronic gastrointestinal disorders are not fully understood."
"In the current study, rifaximin was investigated for its role in activation of the pregnane X receptor (PXR), a nuclear receptor that regulates genes involved in xenobiotic and limited endobiotic deposition and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2007-08-24)
More Articles from Drug Week
- Adverse Drug Reactions
Gastroenterologist-directed sedation safe and effective for endoscopic procedures - Alzheimer Disease
Researchers link metal ions to neurodegenerative disease - Asthma
ESRF lightsource helps tailoring new treatments against asthma - Attention Deficit Hyperactivity Disorder
ADHD Appears to Be Associated With Depressed Dopamine Activity in the Brain - Attention Deficit Hyperactivity Disorder
Gene Variant Is Associated With Brain Anatomy, Clinical Course of ADHD - Battery Technology
Miniature Implanted Devices Could Treat Epilepsy, Glaucoma - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
